Front. Pharmacol. Frontiers in Pharmacology Front. Pharmacol. 1663-9812 Frontiers Media S.A. 1495716 10.3389/fphar.2024.1495716 Pharmacology Correction Corrigendum: Effectiveness, safety, and treatment pattern of sodium zirconium cyclosilicate in Chinese patients with hyperkalemia: interim analysis from a multicenter, prospective, real-world study (Actualize Study) Shen et al. 10.3389/fphar.2024.1495716 Shen Nan 1 Zhang Lihong 2 Yang Jing 3 Lin Yongqiang 4 Liu Xinyu 5 Cai Xudong 6 Cao Juan 7 Zhu Qiang 8 Luo Xun 9 Wan Xin 10 Wu Henglan 11 Ye Jianming 12 Shan Chunyan 13 Xie Hua 14 Wu Yifan 15 Cao Yanping 16 Wang Jianmin 17 Yu Xiaoyong 18 Wang Huimin 19 He Jingdong 20 Tian Shaojiang 21 Wu Fenglei 22 Jiang Xinxin 23 Li Lu 24 Zuo Li 25 Wang Zhaohua 26 Xing Changying 27 Yin Xun 28 Zhao Jianrong 29 Ma Cong 30 Long Gang 31 Li Qing 32 Hu Yao 33 Shi Yifan 34 Lin Hong-Li 1 * 1 The First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning, China 2 The First Hospital of Hebei Medical University, Shijiazhuang, Hebei, China 3 Hefei First People’s Hospital, Huaihe Road, Hefei, Anhui, China 4 Wenzhou Integrated Chinese and Western Medicine Hospital, Wenzhou, Zhejiang, China 5 Nanyang Central Hospital, Nanyang, Henan, China 6 Ningbo traditional Chinese Medicine Hospital, Ningbo, Zhejiang, China 7 Taixing People’s Hospital, Taizhou, Jiangsu, China 8 Xinghua People’s hospital, Taizhou, China 9 Hunan Provincial People’s Hospital, Changsha, Hunan, China 10 The First Hospital of Nanjing, Nanjing, Jiangsu, China 11 The First Hospital of Jiaxing, Jiaxing, Zhejiang, China 12 The First People’s Hospital of Kunshan, Suzhou, Jiangsu, China 13 Chu Hsien-I Memorial Hospital of Tianjin Medical University, Tianjin, China 14 Dalian Ruikaer Renal Disease Hospital, Dalian, Liaoning, China 15 Guangdong Provincial Hospital of Traditional Chinese Medicine, Guangzhou, Guangdong, China 16 Handan First Hospital, Handan, Heibei, China 17 Linfen Central Hospital, Linfen, Shanxi, China 18 Shanxi Provincial Hospital of Chinese Medicine, Shanxi, China 19 Liaoning Health Industry Group Bensteel General Hospital, Benxi, Liaoning, China 20 Nuclear Industry 416 Hospital, Chengdu, Sichuan, China 21 Shiyan People’s Hospital, Shiyan, Hubei, China 22 Qidong People’s Hospital Affiliated Qidong Hospital of Nantong University, Jiangsu, China 23 Sandun District of Zhejiang Hospital, Zhejiang, China 24 The First Affiliated Hospital of Xi’an Medical University, Xi’an, Shaanxi, China 25 Peking University People’s Hospital, Beijing, China 26 Taian City Central Hospital, Tai’an, Shandong, China 27 Jiangsu Province Official Hospital, Nanjing, Jiangsu, China 28 Changshu No. 2 People’s Hospital, Suzhou, Jiangsu, China 29 The Affiliated Hospital of Inner Mongolia Medical University, Hohho, Inner Mongolia, China 30 Anshan Central Hospital, Anshan, Liaoning, China 31 Tianjin People’s Hospital, Tianjin, China 32 Tianjin TEDA Hospital, Tianjin, China 33 Clinical Medical College and Affiliated Hospital of Chengdu University, Chengdu, Sichuan, China 34 AstraZeneca Investment China Co., Medical Affairs, Shanghai, China

Approved by: Frontiers Editorial Office, Frontiers Media SA, Switzerland

 *Correspondence: Hong-Li Lin, linhongli@vip.163.com 01 10 2024 2024 15 1495716 13 09 2024 16 09 2024 Copyright © 2024 Shen, Zhang, Yang, Lin, Liu, Cai, Cao, Zhu, Luo, Wan, Wu, Ye, Shan, Xie, Wu, Cao, Wang, Yu, Wang, He, Tian, Wu, Jiang, Li, Zuo, Wang, Xing, Yin, Zhao, Ma, Long, Li, Hu, Shi and Lin. 2024 Shen, Zhang, Yang, Lin, Liu, Cai, Cao, Zhu, Luo, Wan, Wu, Ye, Shan, Xie, Wu, Cao, Wang, Yu, Wang, He, Tian, Wu, Jiang, Li, Zuo, Wang, Xing, Yin, Zhao, Ma, Long, Li, Hu, Shi and Lin

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

 A Corrigendum on Effectiveness, safety, and treatment pattern of sodium zirconium cyclosilicate in Chinese patients with hyperkalemia: interim analysis from a multicenter, prospective, real-world study (Actualize Study) by Shen N, Zhang L, Yang J, Lin Y, Liu X, Cai X, Cao J, Zhu Q, Luo X, Wan X, Wu H, Ye J, Shan C, Xie H, Wu Y, Cao Y, Wang J, Yu X, Wang H, He J, Tian S, Wu F, Jiang X, Li L, Zuo L, Wang Z, Xing C, Yin X, Zhao J, MaC, Long G, Li Q, Hu Y, Shi Y and Lin H (2024). Front. Pharmacol. 15:1398953. doi: 10.3389/fphar.2024.1398953 hyperkalemia sodium zirconium cyclosilicate safety real-world clinical practice Chinese population section-at-acceptance Cardiovascular and Smooth Muscle Pharmacology

In the published article, there was an error in Affiliation 22. Instead of “Qidong People’s Hospital, The First Hospital of Tsinghua University, Beijing, China,” it should be “Qidong People’s Hospital Affiliated Qidong Hospital of Nantong University, Jiangsu, China.”

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.